Corneal Deposit of Ciprofloxacin after Laser Assisted Subepithelial Keratomileusis Procedure: A Case Report by De Benedetti, Giacomo & Brancaccio, Andrea
Hindawi Publishing Corporation
Journal of Ophthalmology
Volume 2010, Article ID 296034, 3 pages
doi:10.1155/2010/296034
Case Report
Corneal Depositof Ciproﬂoxacin after Laser Assisted
SubepithelialKeratomileusis Procedure:A Case Report
GiacomoDeBenedetti1 andAndreaBrancaccio2
1Hospital Quir´ on Donostia, 7, Parque Alcolea, 20012 San Sebastian, Spain
2Istituto di Chimica del Riconoscimento Molecolare (CNR) c/o Istituto di Biochimica e Biochimica Clinica,
Universit` a Cattolica del Sacro Cuore, Largo Francesco Vito 1, 00168 Roma, Italy
Correspondence should be addressed to Giacomo De Benedetti, g.debenedetti@libero.it
Received 23 March 2010; Accepted 12 May 2010
Academic Editor: Edward Manche
Copyright © 2010 G. De Benedetti and A. Brancaccio. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
Purpose. To report one case of corneal antibiotic deposition after ciproﬂoxacin administration in Laser Assisted Subepithelial
Keratomileusis (LASEK). Methods. One case of post-LASEK treatment resulted in corneal precipitates and poor wound healing.
Debris was analyzed with dark ﬁeld microscopy and placed on a blood-agar plate seeded with a susceptible stain of Staphylococcus
aureus (ATCC 29213). Results. The alterations resolved with discontinuation of ciproﬂoxacin treatment, although some residual
deposits persisted subepithelially for 6 months. Analysis of precipitates revealed polydisperse crystalline needles of 183µma v e r a g e
length (SD = 54µm) and the excised precipitate demonstrated a zone of inhibition. Conclusions. Fluoroquinolone antibiotic drops
have been used extensively in postsurgical treatment of refractive surgery. Corneal precipitates have been previously reported
in the literature, but up to now nothing has been documented after LASEK. Polypharmacy during refractive surgery may impair
epithelialisation,andclinicalmanagementshouldreducetoxicenvironmentandpromoteocularsurfacestabilitywhenperforming
surface ablations.
1.Introduction
Topical ﬂuoroquinolones may be used as antibacterial treat-
ment and have been associated with corneal deposits [1–4]
but nothing has been reported in surface laser ablations. One
case of corneal deposits occurring after the use of topical
ciproﬂoxacin in post-LASEK treatment is presented.
2.MaterialsandMethods
A 59-year-old man opted to be submitted to a LASEK
procedure in December 2008. His best-corrected visual
acuity(BCVA)intherighteye(RE)was20/25with+3,75sph
= +0,50cyl at 30◦ and in the left eye (LE) was 20/25 with
+3.25sph. His maculas showed some alteration in the retinal
pigmented epithelium (RPE). The LASEK procedure was
carried out bilaterally according to Dr. Camellin guidelines,
applying Mytomicin C (MMC) 0.02% for two minutes at the
end of the the laser-ablation [1].
At the end, lidoﬁlcon contact lenses (Actifresh 400 –
Hydron – Hamble, UK) were placed to facilitate epithelial
adhesion.
Ciproﬂoxacin 0.3% four times/day (Oftacilox drops –
Alcon Cusi – El Masnou, Spain) was started two days earlier,
while the postsurgical treatment resulted in
(i) Ciproﬂoxacin 0.3% (as above),
(ii) Diclofenac 0.1% four times/day (Diclofenaco Lepori
monodosis – Angelini – Barcelona, Spain),
(iii) Polividone 5% ad libitum (Oculotect monodosis –
Novartis – Barcelona, Spain).
Debris from the deposit was analyzed with dark ﬁeld
microscopy and placed on a blood-agar plate seeded with
a susceptible stain of Staphylococcus aureus (ATCC 29213).
A standardized laboratory disk of ciproﬂoxacin containing
5g / m Ls e r v e da sac o n t r o l[ 3, 4].2 Journal of Ophthalmology
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Figure 1: Shows the microcistic “caramel-like” opacity of subepithelial, paraoptic, inferior corneal stroma with epithelial discontinuities as
appeared in the beginning (a, b) and after discontinuation of ciproﬂoxacin (c).
3. Results andDiscussion
Thefollow-upduringthethreedaysafterLASEKwasregular,
so the patient was appointed to remove contact lenses (CL)
after three days.
Atthescheduledvisit,hisCLswerenot“insitu”,although
he could not explain when or how he had lost them.
His LE showed a microcistic “caramel-like” opacity
of subepithelial, paraoptic, inferior corneal stroma with
epithelial discontinuities, without any sign of ocular or
periocular inﬂammation (Figures 1(a) and 1(b)).
His RE showed only minor epithelial defects.
Administration of ciproﬂoxacin and diclofenac in his LE
was stopped and substituted with tobramycin 0.3% (Tobrex
– Alcon Cusi – El Masnou, Spain) and dexamethasone
0.1% (Dexafree monodosis – Thea – Barcelona, Spain) six
times/day.
On the following day, RE too showed initial opacities of
the inferior cornea and was moved to the same treatment
of LE, which was gently scraped to analyze the debris as
indicated in Section 2.
After four days the gross opacity in LE disappeared,
although some minor subepithelial deposits and punctiform
desepithelisation still persisted.
RE showed no more peculiar ﬁndings.
Tobramycin was then stopped bilaterally and Dexam-
ethasone was tapered in 2 weeks, switching to Fluorome-
tolone 0.1% (FML drops – Allergan – Westport, Ireland)
three times/day, tapered in 6 weeks bilaterally.
During the whole period the IOP did not show any
hypertensive spike.
After one month, LE opacity was very similar to a vertex
keratopathy (Figure 1(c)), leading to a subepithelial inferior
nubecula persisting for 6 months, with no inﬂuence on his
best-uncorrectedvisionacuity(BUCVA),whichis20/30,nor
on his BCVA (20/25 with +0.50sph).
Depositswereconﬁrmedtobeciproﬂoxacinbydarkﬁeld
microscopy.
The analysis of the images obtained with this technique
revealed the precipitates to be polydisperse crystalline nee-
dles of 183µm average length (SD = 54µm).
The excised precipitate resulted in a zone of inhibition
that measured 22.0mm on ATCC 29213 plate; the control
disk measured 17.0mm after 24 hours.
4. Conclusions
Ciproﬂoxacin, a second-generation ﬂuoroquinolone, is
extensively used in bacterial keratitis, owing to its ease of
availability, broad spectrum of activity, and lack of toxicity.
Although there are many reports of crystalline corneal
deposits occurring with the use of topical ciproﬂoxacin 0.3%
and norﬂoxacin 0.3% [1–7], nothing has been reported after
refractive surgery.
In “in vitro” tear model, drug concentration of
ciproﬂoxacin determined a rapid precipitation that starts at
8  postdose, producing turbidity and a signiﬁcant decline in
soluble drug concentration [4].Journal of Ophthalmology 3
Scuderi et al. in 2003 [8] incubated rabbit corneal
epithelial cells with oﬂoxacin at diﬀerent concentrations
(1.5, 3, and 6mg/mL) and found in all the conditions
tested a statistically signiﬁcant dose- and time-dependent
reduction in cell viability even after 8 hours. A large case-
series of oﬂoxacin deposits after microbial keratitis has been
presented by Mitra et al. in 2007 [9].
Moreover gatiﬂoxacin, a fourth-generation ﬂuoroquin-
olone, has been reported to cause intrastromal crystalline
depositswithacompromisedcornealepithelium,inasimilar
manner to ciproﬂoxacin [10].
Although the use of ciproﬂoxacin alone seems to cause
physicochemical changes in the tear ﬁlm, combination
therapy and other factors probably contribute to alter the pH
thus causing or accelerating the precipitation process.
Such picture could be supported by our case, where LE
was more aﬀected than RE but further studies are needed
to understand if CL loss, presurgical antibiotic treatment,
LASEK technique itself, or the application of MMC could
have aﬀected the re-epithelialisation in this case.
Accumulation of large numbers of dead cells and an
altered general morphology may be further factors inﬂuenc-
ing the formation of deposits.
With reference to the case here described, at the time
of presentation to the corneal service, this patient had been
treated with persistent, preserved and unpreserved topical
drops.
Someofthesetopicalmedications(OftaciloxandTobrex)
contain benzalkonium chloride as preservative, which is
known to disrupt cell walls by emulsifying membrane lipids,
while decreasing epithelial microvilli, corneal wetting and
inhibiting cell motility and surface healing [11].
It is probable that the pH balance had been altered
owing to the interaction of multiple medications which,
in the presence of a compromised ocular surface and
of a nonhealing epithelial defect (due to the loss of the
contact lenses), could result in ciproﬂoxacin precipitation
and relative appearance of corneal deposits.
Discontinuation of ciproﬂoxacin and modiﬁcation of
topical therapy should aid the resolution of these deposits in
most cases, as well as the promotion of epithelialisation, and
the reduction of corneal and conjunctival toxicity.
If deposits persist and prevent epithelialisation, they
should be debrided to permit the cornea to epithelialise, as
in this case, without any adverse outcome, although some
deposits persisted subepithelially despite prolonged topical
cortisone therapy.
In any case, for the future it is hoped that more topical
drugs are going to be available as unpreserved and/or with
higher pH stability, in order to reduce at the lowest level
any possible complication after local treatment, especially in
refractive surgery where patients are very demanding for fast
outcomes.
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